Table 1.
Clonogenic survival of pancreatic cancer cells treated with Gem + MK8776 or Gem + AZD1775 concurrent with roscovitine or exogenous nucleosides. Cells treated under equitoxic conditions with gemcitabine followed by either MK8776 or AZD1775 ± nucleosides or 20 μM roscovitine (as illustrated in Figure 1A) were trypsinized and collected at 30 h (MiaPaCa2, BxPC3, AsPC1, Capan1) or 48 h post-Gem (Panc1) (6 or 24 h MK8776 or AZD1775 ± nucleosides or roscovitine, respectively) and assayed for drug-induced loss of clonogenicity. Non-toxic, similarly sensitizing concentrations of each inhibitor were used: 500 nM MK8776 (MiaPaCa2, BxPC3, Panc1, Capan1), 250 nM MK8776 (AsPC1), 200nM AZD1775 (MiaPaCa2, AsPC1, Panc1) or 100nM AZD1775 (BxPC3, Capan1). Data are the mean clonogenic survival ± SEM (n = 3–7; p < 0.05, one-way ANOVA) and are normalized to the plating efficiency for either MK8776 alone, AZD1775 alone or the combinations of MK8776 or AZD1775 with roscovitine or exogenous nucleosides. Two-way analysis of variance was used to test for statistically significant differences in nucleoside or roscovitine protection from chemosensitization by AZD1775 compared to MK8776 (p < 0.05¥). Under these treatment conditions, roscovitine was not toxic, and did not significantly affect Gem-induced loss of clonogenicity (Suppl. Figure 3).
Cell Line | MiaPaCa2 | BxPC3 | AsPC1 | Panc1 (t = 48h) |
Capan1 |
---|---|---|---|---|---|
Gemcitabine | 0.65 ± 0.04 | 0.44 ± 0.06 | 0.53 ± 0.03 | 0.49 ± 0.06 | 0.61 ± 0.02 |
Gem + MK8776 | 0.07 ± 0.01* | 0.08 ± 0.01* | 0.13 ± 0.03* | 0.05 ± 0.01* | 0.38 ± 0.03* |
Gem + MK8776 + roscovitine | 0.20 ± 0.01*¥ | 0.36 ± 0.07ɸ | 0.56 ± 0.08ɸ | 0.28 ± 0.05*ɸ | 0.66 ± 0.06ɸ |
Gem + MK8776 + nucleosides | 0.19 ± 0.02*¥ | 0.24 ± 0.04 | 0.29 ± 0.05* | 0.34 ± 0.03ɸ | 0.66 ± 0.06ɸ |
Gem + AZD1775 | 0.08 ± 0.01* | 0.10 ± 0.01* | 0.07 ± 0.01* | 0.03 ± 0.01* | 0.17 ± 0.03* |
Gem + AZD1775 + roscovitine | 0.48 ± 0.05*δ¥ | 0.45 ± 0.08δ | 0.56 ± 0.07δ | 0.41 ± 0.06δ | 0.60 ± 0.05δ |
Gem + AZD1775 + nucleosides | 0.32 ± 0.03*δ¥ | 0.33 ± 0.07δ | 0.31 ± 0.01*δ | 0.10 ± 0.01* | 0.55 ± 0.01δ |
Versus Control*, Gem+MK8776ɸ, Gem+AZD1775δ or Gem+MK8776 vs Gem+AZD1775¥ (P < 0.05)